| 2-AG | 2-arachidonoyl-glycerol |
| AA | acetaldehyde |
| Acetyl | acetyl-Coenzyme A |
| ACC | CoA acyl Co-A carboxylase |
| ACE-2 | angiotensin-converting enzyme 2 |
| ACL | ATP citrate lyase |
| ACTA-2 | α-actin 2 |
| ADH | alcohol dehydrogenase |
| ALDH AH |
acetaldehyde dehydrogenase alcoholic hepatitis |
| AIH | autoimmune hepatitis |
| ALD | alcoholic liver disease |
| ALI | acute liver injury |
| ALP | alkaline phosphatase |
| ALT | alanine aminotransferase (glutamic-pyruvic transaminase, GPT) |
| AMA | anti-mitochondrial antibody |
| AMPK | adenosine monophosphate activated kinase |
| ANA | antinuclear antibody |
| AST | aspartate aminotransferase (glutamic-oxalic- transaminase, GOT) |
| ASH | alcoholic steatohepatitis |
| ATP | adenosine triphosphate |
| BMI | body mass index |
| CCK | caspase cleaved cytokeratin (8 & 18)- M30-M 65 |
| C2H5OH | ethyl alcohol, ethanol |
| CoA | coenzyme A |
| COL1A1 | collagen 1A1 |
| CPT-1 | carnitin-palmitoyl-transferase1 |
| CXCL | chemokine |
| CYP2E1 | cytochrome P4502E1 |
| DAMPs | danger-associated molecular patterns |
| DNA | deoxyribonucleic acid |
| EGF | epithelial growth factor |
| Egr-1 | early growth response 1 |
| FA | fatty acids |
| FABP | fatty acid binding protein |
| FASN | fatty acid synthetase |
| FDA | Food and Drug Administration |
| FFA | free fatty acid |
| FL | fatty liver |
| FN1 | fibronectin 1 |
| GGT | γ-glutamyl-transferase |
| GSH | glutathione |
| H3K9 | tri-methylation of lysine 9 of histone 3 |
| HER | hydroxyethyl radical |
| HGF | hepatocyte growth factor |
| ICD | International Classification of Diseases |
| IFN | interferon |
| IL | interleukine |
| LPB | LPS binding protein |
| LPS | lipopolysaccharides |
| KC | Kupfer cells |
| MAA | malondialdehyde |
| MAFLD | metabolic associated fatty liver disease |
| MEOS | microsomal ethanol oxidizing system |
| Mean ± SD | mean ± standard deviation |
| mTOR | mammalian target of rapamycin |
| NAD+ | nicotin-amide-adenine dinucleotide |
| NADH | nicotin-amide-adenine dinucleotide-hydrogen |
| NADP+ | nicotinamide adenine dinucleotide phosphate |
| NADPH | reduced nicotinamide adenine dinucleotide phosphate |
| NRF2 | nuclear factor-erythroid 2-related factor 2 |
| PAMP | pathogen-associated molecular patterns |
| PhET | phosphatidyl ethanol |
| PPAR alpha | peroxisome proliferator—activated receptor alpha |
| PRRs | pattern-recognition receptors |
| PUFA | poly-unsaturated fatty acids |
| ROS | reactive oxygen specie |
| SIRT1 | sirtuin 1 |
| SRPK2 | serine-arginine-rich protein kinase 2 (SRPK2) |
| SOCS | suppressor of cytokine signalling |
| SRABP1c | sterol element binding protein 1c |
| SREBP-1 | sterol-regulatory element binding protein-1 |
| STAT3 | signal transducers and activator of transcriptor 3 |
| TGF-β | transforming growth factor-β |
| TIMP1 | TIMP metallopeptidase inhibitor |
| TLR4 | toll-like receptor 4 |
| TNF α | tumour necrosis factor α |
| VLDL | very-low-density lipoproteins |